# EDGAR Filing Document

**Accession Number:** 0001090372
**File Stem:** 0001145549-23-001346
**Filing Date:** 2023-1
**Character Count:** 24294
**Document Hash:** 1984e87dd7dee136075996fd031a52fb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001145549-23-001346.hdr.sgml**: 20230113

**ACCESSION NUMBER**: 0001145549-23-001346

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221130

**FILED AS OF DATE**: 20230113

**DATE AS OF CHANGE**: 20230113

**PERIOD START**: 20230831

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Jacob Funds Inc.
- **CENTRAL INDEX KEY:** 0001090372
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09447
- **FILM NUMBER:** 23528122

**BUSINESS ADDRESS:**
- **STREET 1:** 727 2ND STREET, #106
- **CITY:** HERMOSA BEACH
- **STATE:** CA
- **ZIP:** 90254
- **BUSINESS PHONE:** 310-421-4942

**MAIL ADDRESS:**
- **STREET 1:** 727 2ND STREET, #106
- **CITY:** HERMOSA BEACH
- **STATE:** CA
- **ZIP:** 90254

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JACOB INTERNET FUND INC
- **DATE OF NAME CHANGE:** 20060106

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JACOB INTERNET FUND
- **DATE OF NAME CHANGE:** 20060106

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JACOB INTERNET FUND INC
- **DATE OF NAME CHANGE:** 19990713

## Series and Classes Contracts Data

### Jacob Forward ETF (Series ID: S000071967)

| Class ID   | Class Name        | Ticker Symbol   |
|:---|:---|:---|
| C000227599 | Jacob Forward ETF | JFWD            |

## Nport-Ex

---

| | | | |
|:---|:---|:---|:---|
| **Jacob Forward ETF** |  |  | |
| **Schedule of Investments <sup>(+)</sup>** | **Schedule of Investments <sup>(+)</sup>** | **Schedule of Investments <sup>(+)</sup>** | |
| **November 30, 2022 (Unaudited)** | **November 30, 2022 (Unaudited)** | **November 30, 2022 (Unaudited)** | |
| **Shares** |  |  | **Value** |
| |  | **COMMON STOCKS - 100.0%** | |
| |  | **Biological Products (Diagnostic Substances) - 7.0%** | |
| 1237 |  | Beam Therapeutics, Inc. \* | $57137 |
| 842 |  | CRISPR Therapeutics AG \*^ | 46133 |
| 755 |  | Krystal Biotech, Inc. \* | 58693 |
| 1982 |  | Twist Bioscience Corp. \* | 54208 |
|  |  |  | 216171 |
|  |  | **Business Services - 12.8%** |  |
| 9730 |  | OptimizeRx Corp. \* | 205206 |
| 5065 |  | Zillow Group, Inc. - Class C \* | 192369 |
|  |  |  | 397575 |
|  |  | **Catalog & Mail-Order Houses - 1.5%** |  |
| 535 |  | Alibaba Group Holding Ltd. - ADR \*^ | 46845 |
|  |  | **Computer Peripheral Equipment - 2.0%** |  |
| 485 |  | Impinj, Inc. \* | 61862 |
|  |  | **Computer Programming Services - 7.8%** |  |
| 4655 |  | Doximity, Inc. - Class A \* | 158223 |
| 3085 |  | HashiCorp, Inc. - Class A\* | 84221 |
|  |  |  | 242444 |
|  |  | **Computer Programming, Data Processing, Etc. - 5.0%** |  |
| 850 |  | MongoDB, Inc. \* | 129787 |
| 11418 |  | Nextdoor Holdings, Inc. \* | 25691 |
|  |  |  | 155478 |
|  |  | **Industrial Organic Chemicals - 6.0%** |  |
| 50053 |  | Amyris, Inc. \* | 86592 |
| 18362 |  | Codexis, Inc. \* | 100440 |
|  |  |  | 187032 |
|  |  | **Medical Laboratories - 2.8%** |  |
| 5604 |  | CareDx, Inc. \* | 72572 |
| 5991 |  | DermTech, Inc. \* | 15277 |
|  |  |  | 87849 |
|  |  | **Miscellaneous Amusement & Recreation - 4.5%** |  |
| 8990 |  | DraftKings, Inc. - Class A\* | 137726 |
|  |  | **Nonstore Retailers - 3.4%** |  |
| 21878 |  | Rover Group, Inc. \* | 105452 |
|  |  | **Patent Owners & Lessors - 5.6%** |  |
| 9425 |  | Digital Turbine, Inc. \* | 172100 |
|  |  | **Pharmaceutical Preparations - 11.4%** |  |
| 1520 |  | Apellis Pharmaceuticals, Inc. \* | 75894 |
| 761 |  | Arcturus Therapeutics Holdings, Inc. \* | 14033 |
| 42149 |  | Heron Therapeutics, Inc. \* | 114223 |
| 5600 |  | Ideaya Biosciences, Inc. \* | 100128 |
| 2651 |  | Schrodinger, Inc. \* | 47718 |
|  |  |  | 351996 |
|  |  | **Prepackaged Software - 17.9%** |  |
| 2138 |  | Block, Inc. \* | 144892 |
| 2696 |  | Cloudflare, Inc. - Class A \* | 132481 |
| 10310 |  | Cvent Holding Corp. \* | 57736 |
| 27755 |  | Porch Group, Inc. \* | 56620 |
| 2815 |  | Twilio, Inc. - Class A\* | 137991 |
| 22281 |  | WM Technology, Inc. \* | 26069 |
|  |  |  | 555789 |
|  |  | **State Commerical Banks - 3.3%** |  |
| 3765 |  | Silvergate Capital Corp. - Class A \* | 103274 |
|  |  | **Surgical & Medical Instruments & Apparatus - 9.0%** |  |
| 27050 |  | Alphatec Holdings, Inc. \* | 277533 |
|  |  | **TOTAL COMMON STOCKS (Cost $6,103,028)** | 3099126 |
|  |  | **MONEY MARKET FUND - 0.0%** |  |
| 972 |  | First American Government Obligations Fund - Class X, 3.67% <sup>(a)</sup> | 972 |
|  |  | **TOTAL MONEY MARKET FUND (Cost $972)** | 972 |
|  |  | **TOTAL INVESTMENTS (Cost $6,104,000) - 100.0%** | 3100098 |
|  |  | **LIABILITIES IN EXCESS OF OTHER ASSETS - 0.0%** | (704) |
|  |  | **TOTAL NET ASSETS - 100.0%** | $3099394 |
|  | (+) | Schedule of Investments is classified using the U.S. Securities and Exchange Commission's Standard Industrial Classification (SIC) Code List. |  |
|  | \* | Non Income Producing. |  |
|  | ^ | U.S. Dollar-denominated foreign security. |  |
|  | ADR | American Depositary Receipt. |  |
|  | (a) | 7-day yield. |  |

---

------

---

| |
|:---|
| **Jacob Forward ETF Fund Summary of Fair Value Exposure (Unaudited)** |
| Investment securities traded on a national securities exchange are valued at their market value determined by their last sales price in the principal market in which these securities are normally traded (except those traded on the NASDAQ National Market and Capital Market exchanges which are valued at the NASDAQ Official Closing Price ("NOCP")), unless there are no transactions on the valuation date, in which case they are valued at the mean between the closing bid and ask prices. Securities traded over-the-counter are valued at the last reported sales price unless there is no reported sales price, in which case the mean between the closing bid and ask prices is used. Foreign securities, currencies and other assets denominated in foreign currencies are translated into U.S. dollars at the exchange rate of such currencies. Foreign equity securities are valued at the last sale price at the close of the exchange on which the security is principally traded. The Jacob Forward ETF (the "Fund") values foreign securities at fair value, using fair valuation procedures approved by the Board of Directors, taking into account the occurrence of events after the close of foreign markets in calculating the net asset value ("NAV"). In such cases, use of fair valuation can reduce the investor's ability to seek profit by estimating the Fund's NAV in advance of the time the NAV is calculated. The Board of Directors have retained an independent fair value pricing service to assist in valuing foreign securities held by the Fund. Debt securities with maturities of 60 days or less are valued at amortized cost, which approximates market value. Short-term securities with 60 days or less remaining to maturity are, unless conditions indicate otherwise, amortized to maturity based on their cost to the Fund if acquired within 60 days of maturity or, if already held by the Fund on the 60th day, based on the value determined on the 61st day. If amortized cost does not approximate fair value, short-term securities are reported at fair value. Where market quotations are not readily available, are unreliable or when values have been materially affected by events occurring before the close of U.S. markets but after the close of the securities' primary markets, securities are valued at fair value using procedures approved by the Board of Directors that are designed to determine a security's fair value. |
| The Fund adheres to fair valuation accounting standards which provide an authoritative definition of fair value and sets out a hierarchy for measuring fair value. These standards require disclosures about the various inputs and valuation techniques used to develop the measurements of fair value and a discussion in changes in valuation techniques and related inputs during the period. These standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy is organized into three levels based upon the assumptions (referred to as "inputs") used in pricing the asset or liability. These standards state that "observable inputs" reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from independent sources and "unobservable inputs" reflect an entity's own assumptions about the assumptions market participants would use in pricing the asset or liability. |
| Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in the three broad levels listed below:<br>Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access.<br> Level 2 - Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.<br> Level 3 - Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Fund's own assumptions about the assumptions a market participant would use in valuing the asset or liability, and based on the best information available. |
| The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. |
| The following is a summary of the inputs used to value the Fund's investments as of November 30, 2022: |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Common Stocks** | | | | |
| Prepackaged Software | $555789 | $- | $- | $555789 |
| Business Services | 397575 | - | - | 397575 |
| Pharmaceutical Preparations | 351996 | - | - | 351996 |
| Surgical and Medical Instruments and Apparatus | 277533 | - | - | 277533 |
| Biological Products (No Diagnostic Substances) | 216171 | - | - | 216171 |
| Industrial Organic Chemicals | 187032 | - | - | 187032 |
| Patent Owners & Lessors | 172100 | - | - | 172100 |
| Computer Programming Services | 242444 | - | - | 242444 |
| Computer Programming, Data Processing, Etc. | 155478 | - | - | 155478 |
| Miscellaneous Amusement & Recreation | 137726 | - | - | 137726 |
| Nonstore Retailers | 105452 | - | - | 105452 |
| State Commercial Banks | 103274 | - | - | 103274 |
| Medical Laboratories | 87849 | - | - | 87849 |
| Computer Peripheral Equipment | 61862 | - | - | 61862 |
| Catalog & Mail-Order Houses | 46845 | - | - | 46845 |
| **Total Common Stocks** | 3099126 | - | - | 3099126 |
| **Short Term Investment** |  |  |  |  |
| Money Market Fund | 972 | - | - | 972 |
| **Total Investments in Securities** | $3100098 | $- | $- | $3100098 |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Jacob Funds Inc.

- **b. Investment Company Act file number:** 811-09447

- **c. CIK number of Registrant:** 0001090372

- **d. LEI of Registrant:** 5493006PQB1DQR6P2S14

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 727 2nd Street

  - **City:** Hermosa Beach

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 90254

  - **Telephone number:** 424-237-2164

**Item A.2. Information about the Series.**

- **a. Name of Series:** Jacob Forward ETF

- **b. EDGAR series identifier (if any):** S000071967

- **c. LEI of Series:** 549300TQFVM16K87YK51

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-08-31

- **b. Date as of which information is reported:** 2022-11-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $3110961.93

**Total Liabilities:** $11927.80

**Net Assets:** $3099034.13

**Cash Not Reported:** $0.01

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000227599 | -6.69%               | 1.75%                | -4.45%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $24087.24                | $-250674.54                                |
| Month 2  | $20162.09                | $37748.44                                  |
| Month 3  | $-77218.43               | $-65310.06                                 |

### Schedule of Portfolio Investments

| Name                           | Title                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Alibaba Group Holding Ltd      | Alibaba Group Holding Ltd                  | CUSIP: 01609W102<br>LEI: 5493001NTNQJDH60PM02 | Long             | EC               | CORP              | CN        |       535 | NS      | $46844.60     | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphatec Holdings Inc          | Alphatec Holdings Inc                      | CUSIP: 02081G201<br>LEI: 549300EZE8CQ8K65FS24 | Long             | EC               | CORP              | US        |     27050 | NS      | $277533.00    | 8.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Amyris Inc                     | Amyris Inc                                 | CUSIP: 03236M200<br>LEI: 549300BG17WCUK6EIM58 | Long             | EC               | CORP              | US        |     50053 | NS      | $86591.69     | 2.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc    | Apellis Pharmaceuticals Inc                | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |      1520 | NS      | $75893.60     | 2.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcturus Therapeutics Holdings | Arcturus Therapeutics Holdings Inc         | CUSIP: 03969T109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       761 | NS      | $14032.84     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc          | Beam Therapeutics Inc                      | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1237 | NS      | $57137.03     | 1.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Cvent Holding Corp             | Cvent Holding Corp                         | CUSIP: 126677103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10310 | NS      | $57736.00     | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| MongoDB Inc                    | MongoDB Inc                                | CUSIP: 60937P106<br>LEI: 549300TPTG69WKWE1Z37 | Long             | EC               | CORP              | US        |       765 | NS      | $116807.85    | 3.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Nextdoor Holdings Inc          | Nextdoor Holdings Inc                      | CUSIP: 65345M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11418 | NS      | $25690.50     | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| OptimizeRx Corp                | OptimizeRx Corp                            | CUSIP: 68401U204<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9730 | NS      | $205205.70    | 6.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Porch Group Inc                | Porch Group Inc                            | CUSIP: 733245104<br>LEI: 549300NXEI7CVW8IXQ90 | Long             | EC               | CORP              | US        |     27755 | NS      | $56620.20     | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Rover Group Inc                | Rover Group Inc                            | CUSIP: 77936F103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21878 | NS      | $105451.96    | 3.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Schrodinger Inc/United States  | Schrodinger Inc/United States              | CUSIP: 80810D103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2651 | NS      | $47718.00     | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Silvergate Capital Corp        | Silvergate Capital Corp                    | CUSIP: 82837P408<br>LEI: BPE6FTXDZEBNAGIT2T19 | Long             | EC               | CORP              | US        |      3600 | NS      | $98748.00     | 3.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Block Inc                      | Block Inc                                  | CUSIP: 852234103<br>LEI: 549300OHIIUWSTIZME52 | Long             | EC               | CORP              | US        |      2138 | NS      | $144892.26    | 4.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Twilio Inc                     | Twilio Inc                                 | CUSIP: 90138F102<br>LEI: 5493004W8TRGD63APX93 | Long             | EC               | CORP              | US        |      2815 | NS      | $137991.30    | 4.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corp          | Twist Bioscience Corp                      | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |      1982 | NS      | $54207.70     | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| WM Technology Inc              | WM Technology Inc                          | CUSIP: 92971A109<br>LEI: 549300APSNIYJ4PTIL34 | Long             | EC               | CORP              | US        |     22281 | NS      | $26068.77     | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Zillow Group Inc               | Zillow Group Inc                           | CUSIP: 98954M200<br>LEI: 2549002XEELQDIR6FU05 | Long             | EC               | CORP              | US        |      5065 | NS      | $192368.70    | 6.21%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG         | CRISPR Therapeutics AG                     | CUSIP: N/A<br>LEI: 506700O6IRRIQLT3W370       | Long             | EC               | CORP              | CH        |       842 | NS      | $46133.18     | 1.49%             |  |  |  | No            |                  1 | On Loan: No      |
| CareDx Inc                     | CareDx Inc                                 | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               | CORP              | US        |      5604 | NS      | $72571.80     | 2.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Cloudflare Inc                 | Cloudflare Inc                             | CUSIP: 18915M107<br>LEI: 5493007DY18BGNLDWU14 | Long             | EC               | CORP              | US        |      2696 | NS      | $132481.44    | 4.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Codexis Inc                    | Codexis Inc                                | CUSIP: 192005106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18362 | NS      | $100440.14    | 3.24%             |  |  |  | No            |                  1 | On Loan: No      |
| DermTech Inc                   | DermTech Inc                               | CUSIP: 24984K105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5991 | NS      | $15277.05     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Digital Turbine Inc            | Digital Turbine Inc                        | CUSIP: 25400W102<br>LEI: 549300D0WZR1VI2QGB24 | Long             | EC               | CORP              | US        |      9425 | NS      | $172100.50    | 5.55%             |  |  |  | No            |                  1 | On Loan: No      |
| DraftKings Inc                 | DraftKings Inc                             | CUSIP: 26142V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8990 | NS      | $137726.80    | 4.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Doximity Inc                   | Doximity Inc                               | CUSIP: 26622P107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4655 | NS      | $158223.45    | 5.11%             |  |  |  | No            |                  1 | On Loan: No      |
| First American Government Obli | First American Government Obligations Fund | CUSIP: 31846V336<br>LEI: 549300R5MYM6VZF1RM44 | Long             | STIV             | RF                | US        |       972 | NS      | $971.59       | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| HashiCorp Inc                  | HashiCorp Inc                              | CUSIP: 418100103<br>LEI: 549300XGOB9ZFQHMIP56 | Long             | EC               | CORP              | US        |      3085 | NS      | $84220.50     | 2.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Heron Therapeutics Inc         | Heron Therapeutics Inc                     | CUSIP: 427746102<br>LEI: 549300DR2I1DOPD2IX53 | Long             | EC               | CORP              | US        |     42149 | NS      | $114223.79    | 3.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences Inc         | Ideaya Biosciences Inc                     | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |      6300 | NS      | $112644.00    | 3.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Impinj Inc                     | Impinj Inc                                 | CUSIP: 453204109<br>LEI: 549300M26VGKSMMWWN17 | Long             | EC               | CORP              | US        |       510 | NS      | $65050.50     | 2.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech Inc            | Krystal Biotech Inc                        | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |       755 | NS      | $58693.70     | 1.89%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-01-11

**Name of Applicant:** Jacob Funds Inc.

**Signature:** /s/ Ryan Jacob

**Name of Signer:** Jacob Funds Inc.

**Title:** President/Principal Executive Officer